Historical perspectives on cadmium toxicology

Area of Science:

• Environmental Toxicology
• Occupational Health
• Human Health Risk Assessment

Background:

• Historical health effects of cadmium (Cd) exposure documented since 1858, including respiratory, gastrointestinal, and bone issues.
• The itai-itai disease in Japan highlighted Cd-induced renal osteomalacia, leading to studies on Cd toxicokinetics and binding to metallothionein.
• International warnings on Cd pollution risks emerged in the 1970s, with ongoing uncertainty regarding reproductive and carcinogenic effects in humans.

Observation:

• The World Health Organization identified renal dysfunction as the critical effect of cadmium exposure in 1992.
• Epidemiological studies from the 1990s and 2000s reported adverse health effects from low-level environmental cadmium exposure across global populations.
• Early research identified metallothionein's role in cadmium toxicology, paving the way for biomarker development.

Findings:

• Biomarkers such as metallothionein gene expression in lymphocytes and autoantibodies in blood plasma are used to assess susceptibility to Cd-related renal dysfunction.
• Recent studies indicate that very low cadmium exposure levels can induce renal dysfunction in susceptible human populations.
• Individuals with diabetes are identified as a sensitive subgroup potentially at higher risk for cadmium-induced renal dysfunction.

Implications:

• Understanding cadmium's long-term health impacts, especially renal effects, is crucial for public health.
• Development of sensitive biomarkers can aid in identifying at-risk populations for targeted interventions.
• Further research is needed to fully quantify reproductive and carcinogenic risks and to establish safe exposure limits for cadmium.